NCT04956783View on ClinicalTrials.gov

Occurrence of Adverse Effects With Immune Checkpoint Inhibitors Between a Single and Double Dose Regimen

CompletedOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions

Cancer

Trial Locations (1)

34295

Uhmontpellier, Montpellier

All Listed Sponsors

lead

University Hospital, Montpellier

OTHER